Literature DB >> 15548645

Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors.

Martin Horak1, Kamil Vlcek, Milos Petrovic, Hana Chodounska, Ladislav Vyklicky.   

Abstract

NMDA receptors are highly expressed in the CNS and are involved in excitatory synaptic transmission and synaptic plasticity as well as excitotoxicity. They have several binding sites for allosteric modulators, including neurosteroids, endogenous compounds synthesized by the nervous tissue and expected to act locally. Whole-cell patch-clamp recording from human embryonic kidney 293 cells expressing NR1-1a/NR2B receptors revealed that neurosteroid pregnenolone sulfate (PS) (300 microm), when applied to resting NMDA receptors, potentiates the amplitude of subsequent responses to 1 mm glutamate fivefold and slows their deactivation twofold. The same concentration of PS, when applied during NMDA receptor activation by 1 mm glutamate, has only a small effect. The association and dissociation rate constants of PS binding and unbinding from resting NMDA receptors are estimated to be 3.3 +/- 2.0 mm(-1)sec(-1) and 0.12 +/- 0.02 sec(-1), respectively, corresponding to an apparent affinity K(d) of 37 microm. The results of experiments indicate that the molecular mechanism of PS potentiation of NMDA receptor responses is attributable to an increase in the peak channel open probability (P(o)). Responses to glutamate recorded in the continuous presence of PS exhibit marked time-dependent decline. Our results indicate that the decline is induced by a change of the NMDA receptor affinity for PS after receptor activation. These results suggest that the PS is a modulator of NMDA receptor P(o), the effectiveness of which is lowered by glutamate binding. This modulation may have important consequences for the neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548645      PMCID: PMC6730288          DOI: 10.1523/JNEUROSCI.2099-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

Review 1.  Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways.

Authors:  Rémy Schlichter; Anne Florence Keller; Mathias De Roo; Jean-Didier Breton; Perrine Inquimbert; Pierrick Poisbeau
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.

Authors:  Daniel T Monaghan; Mark W Irvine; Blaise Mathias Costa; Guangyu Fang; David E Jane
Journal:  Neurochem Int       Date:  2012-01-17       Impact factor: 3.921

3.  Key amino acid residues within the third membrane domains of NR1 and NR2 subunits contribute to the regulation of the surface delivery of N-methyl-D-aspartate receptors.

Authors:  Martina Kaniakova; Barbora Krausova; Vojtech Vyklicky; Miloslav Korinek; Katarina Lichnerova; Ladislav Vyklicky; Martin Horak
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

4.  The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.

Authors:  Steven M Paul; James J Doherty; Albert J Robichaud; Gabriel M Belfort; Brian Y Chow; Rebecca S Hammond; Devon C Crawford; Andrew J Linsenbardt; Hong-Jin Shu; Yukitoshi Izumi; Steven J Mennerick; Charles F Zorumski
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

Review 5.  Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Authors:  Laetitia Mony; James N C Kew; Martin J Gunthorpe; Pierre Paoletti
Journal:  Br J Pharmacol       Date:  2009-07-08       Impact factor: 8.739

6.  Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.

Authors:  Weiting Tang; Ding Liu; Stephen F Traynelis; Hongjie Yuan
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

7.  An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups.

Authors:  Riley Perszyk; Brooke M Katzman; Hirofumi Kusumoto; Steven A Kell; Matthew P Epplin; Yesim A Tahirovic; Rhonda L Moore; David Menaldino; Pieter Burger; Dennis C Liotta; Stephen F Traynelis
Journal:  Elife       Date:  2018-05-24       Impact factor: 8.140

8.  Low concentrations of neuroactive steroids alter kinetics of [3H]ifenprodil binding to the NMDA receptor in rat frontal cortex.

Authors:  Tobias Johansson; Per-Anders Frändberg; Fred Nyberg; Pierre Le Grevès
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 9.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

Review 10.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.